» Articles » PMID: 17321313

Evolution of China's Response to HIV/AIDS

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2007 Feb 27
PMID 17321313
Citations 224
Authors
Affiliations
Soon will be listed here.
Abstract

Four factors have driven China's response to the HIV/AIDS pandemic: (1) existing government structures and networks of relationships; (2) increasing scientific information; (3) external influences that underscored the potential consequences of an HIV/AIDS pandemic and thus accelerated strategic planning; and (4) increasing political commitment at the highest levels. China's response culminated in legislation to control HIV/AIDS-the AIDS Prevention and Control Regulations. Three major initiatives are being scaled up concurrently. First, the government has prioritised interventions to control the epidemic in injection drug users, sex workers, men who have sex with men, and plasma donors. Second, routine HIV testing is being implemented in populations at high risk of infection. Third, the government is providing treatment for infected individuals. These bold programmes have emerged from a process of gradual and prolonged dialogue and collaboration between officials at every level of government, researchers, service providers, policymakers, and politicians, and have led to decisive action.

Citing Articles

Evolution of HIV Epidemic and Emerging Challenges - China, 1989-2023.

Cai C, Tang H, Li D, Qin Q, Chen F, Jin Y China CDC Wkly. 2024; 6(48):1251-1256.

PMID: 39698324 PMC: 11649988. DOI: 10.46234/ccdcw2024.251.


Spatiotemporal Analysis of HIV/AIDS Incidence in China From 2009 to 2019 and Its Association With Socioeconomic Factors: Geospatial Study.

Xie Z, Chen B, Duan Z JMIR Public Health Surveill. 2024; 10:e56229.

PMID: 38848123 PMC: 11193075. DOI: 10.2196/56229.


Evolving Challenges in the Implementation of China's "Four Frees and One Care" Policy for HIV/AIDS.

Xie Z, Duan Z Risk Manag Healthc Policy. 2024; 17:1315-1321.

PMID: 38778921 PMC: 11108755. DOI: 10.2147/RMHP.S459173.


Are All Gay Men at Risk of Developing HIV/AIDS? Why China's Mass HIV Testing Has Majorly Targeted Gay Men in the Era of Biomedicalization.

Yang L, Sun Z Am J Mens Health. 2024; 18(1):15579883241230165.

PMID: 38321807 PMC: 10851740. DOI: 10.1177/15579883241230165.


Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China.

Li M, Cao Y, Huang H, Qin G, Chu M, Zou M BMC Public Health. 2023; 23(1):2228.

PMID: 37953277 PMC: 10641994. DOI: 10.1186/s12889-023-17052-1.


References
1.
Gossop M, Marsden J, Stewart D, Treacy S . Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study. AIDS Care. 2002; 14(1):77-93. DOI: 10.1080/09540120220097955. View

2.
Wu Z, Rou K, Xu C, Lou W, Detels R . Acceptability of HIV/AIDS counseling and testing among premarital couples in China. AIDS Educ Prev. 2005; 17(1):12-21. DOI: 10.1521/aeap.17.1.12.58686. View

3.
Zhao C, Liu Z, Zhao D, Liu Y, Liang J, Tang Y . Drug abuse in China. Ann N Y Acad Sci. 2004; 1025:439-45. DOI: 10.1196/annals.1316.054. View

4.
Liu H, Grusky O, Li X, Ma E . Drug users: a potentially important bridge population in the transmission of sexually transmitted diseases, including AIDS, in China. Sex Transm Dis. 2006; 33(2):111-7. DOI: 10.1097/01.olq.0000199762.28231.ee. View

5.
Zhang H, Stanton B, Li X, Mao R, Sun Z, Kaljee L . Perceptions and attitudes regarding sex and condom use among Chinese college students: a qualitative study. AIDS Behav. 2004; 8(2):105-17. DOI: 10.1023/B:AIBE.0000030242.46843.71. View